The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability

被引:56
|
作者
Lazarski, Christopher A.
Chaves, Francisco A.
Sant, Andrea J.
机构
[1] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst, Rochester, NY 14642 USA
[2] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[3] Univ Chicago, Comm Immunol, Dept Biol Sci, Chicago, IL 60637 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2006年 / 203卷 / 05期
关键词
D O I
10.1084/jem.20060058
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
DM edits the peptide repertoire presented by major histocompatibility complex class II molecules by professional antigen-presenting cells (APCs), favoring presentation of some peptides over others. Despite considerable research by many laboratories, there is still significant uncertainty regarding the biochemical attributes of class II - peptide complexes that govern their susceptibility to DM editing. Here, using APCs that either do or do not express DM and a set of unrelated antigens, we found that the intrinsic kinetic stability of class II - peptide complexes is tightly correlated with the effects of DM editing within APCs. Furthermore, through the use of kinetic stability variants of three independent peptides, we demonstrate that increasing or decreasing the kinetic stability of class II - peptide complexes causes a corresponding alteration in DM editing. Finally, we show that the spontaneous kinetic stability of class II complexes correlates directly with the efficiency of presentation by DM+ APCs and the immunodominance of that class II - peptide complex during an immune response. Collectively, these results suggest that the pattern of DM editing in APCs can be intentionally changed by modifying class II - peptide interactions, leading to the desired hierarchy of presentation on APCs, thereby promoting recruitment of CD4 T cells specific for the preferred peptides during an immune response.
引用
收藏
页码:1319 / 1328
页数:10
相关论文
共 50 条
  • [41] Genetic engineering of antigen presentation of MHC class-II restricted antigens
    Wang, RF
    Wang, X
    Atwood, A
    Rosenberg, SA
    FASEB JOURNAL, 1999, 13 (04): : A275 - A275
  • [42] Antigen presentation by MHC class II molecules
    Weenink, SM
    Gautam, AM
    IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (01): : 69 - 81
  • [43] Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing
    Hastings, K. Taraszka
    Lackman, Rebecca L.
    Cresswell, Peter
    JOURNAL OF IMMUNOLOGY, 2006, 177 (12): : 8569 - 8577
  • [44] Diversity in MHC class II antigen presentation
    Robinson, JH
    Delvig, AA
    IMMUNOLOGY, 2002, 105 (03) : 252 - 262
  • [45] Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis δ antigen
    Accapezzato, D
    Nisini, R
    Paroli, M
    Bruno, G
    Bonino, F
    Houghton, M
    Barnaba, V
    JOURNAL OF IMMUNOLOGY, 1998, 160 (11): : 5262 - 5266
  • [46] Enhancement of MHC class II-restricted responses by receptor-mediated uptake of peptide antigens
    Zaliauskiene, L
    Kang, SY
    Sparks, K
    Zinn, KR
    Schwiebert, LM
    Weaver, CT
    Collawn, JF
    JOURNAL OF IMMUNOLOGY, 2002, 169 (05): : 2337 - 2345
  • [47] Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing
    Moss, CX
    Villadangos, JA
    Watts, C
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (12) : 3442 - 3451
  • [48] Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability
    vanderBurg, SH
    Visseren, MJW
    Brandt, RMP
    Kast, WM
    Melief, CJM
    JOURNAL OF IMMUNOLOGY, 1996, 156 (09): : 3308 - 3314
  • [49] INHIBITION BY BREFELDIN-A OF THE SPECIFIC B-CELL ANTIGEN PRESENTATION TO MHC CLASS II-RESTRICTED T-CELLS
    KAKIUCHI, T
    TAKATSUKI, A
    WATANABE, M
    NARIUCHI, H
    JOURNAL OF IMMUNOLOGY, 1991, 147 (10): : 3289 - 3295
  • [50] Signaling in primary thymocytes after presentation of altered peptide ligands by antigen-presenting cells or MHC-peptide tetramers
    Smyth, LA
    Reynolds, L
    Tyrrell, R
    Williams, O
    Norton, T
    Schumacher, T
    Tybulewicz, V
    Ley, SC
    Kioussis, D
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1999, 64 : 275 - 281